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Abstract 
The zebrafish is a powerful genetic model organism. In recent years, zebrafish (Danio rerio) 
has been increasingly used to model human diseases. Due to a number of recent technological 
advancements, the genetic tool box is now also stocked with sophisticated transgenic and 
reverse genetic tools.  Here, we focus on both commonly used and recently established 
reverse genetic and transgenic tools available in zebrafish. These new developments make the 
zebrafish an even more attractive animal model in comparative endocrinology. 
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Introduction 
The last three decades have seen the establishment of the zebrafish as a major vertebrate 
model organism for studies of human diseases. The zebrafish made its first splash as a model 
for genetic control of vertebrate development due to its favorable biological characteristics 
such as high fecundity, transparency and external development of embryos [45]. Zebrafish 
genetics entered the picture and gained prominence with the two first large-scale mutagenesis 
screens performed in any vertebrate species [8,16]. At this time in the 1990s and in the 
following years, zebrafish genetics was nearly exclusively confined to forward genetic 
studies, exploiting the huge number of available mutant strains, many of which proofed to be 
relevant for our understanding of mechanisms of pathogenesis of a number of human diseases 
[12,28]. Genetic studies of human disorders benefit from the investigation of specific target 
genes of interest. In contrast to forward genetics, the lack of tools to manipulate specific 
genes of interest hindered the realization of the full potential of the zebrafish for modeling 
human diseases [43]. However, recent technological advances, mainly in anti-sense 
morpholino mediated gene knockdown, transgenics using the Tol2 system and the induction 
of heritable genetic alterations with zinc finger nucleases, TALENs and TILLING technology 
heralds a new era in zebrafish reverse genetics.  
The strengths of zebrafish have been largely realized in the study of developmental biology, 
as is also the case for endocrine systems in zebrafish [29]. Studies on zebrafish endocrine 
systems have revealed that the endocrine systems between humans and zebrafish are 
remarkably well conserved [30]. Significantly, studies on zebrafish endocrine systems show 
that the development of endocrine systems mostly complete within 5 days post fertilization 
(dpf) in zebrafish. In other words, it is possible to model the human endocrine systems in 
developing zebrafish, taking full advantage of the strengths of this animal model.   
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In this review, we discuss several reverse genetics approaches that have been established in 
zebrafish as well as emerging techniques for targeted gene knockout including TALENs, and 
their application for studies of human endocrine systems. 
 
Reverse Genetic Approaches in Zebrafish 
The mouse model has been a dominant system to study disease related genes because of 
conservation of gross anatomy with humans and sophisticated gene manipulation techniques 
made possible by homologous recombination [47]. Although application of gene targeting by 
homologous recombination has been explored in zebrafish, these attempts have only met with 
little success, mainly due to the absence of proper embryonic stem cells [46]. However, other 
methods to manipulate gene function have gained prominence in the zebrafish. Morpholino 
antisense oligonucleotides and TILLING are two main reverse genetics methods, and now 
artificial endonuclease enzymes, ZFNs and TALENs, are emerging as a new technique to 
study specific genes of interest. 
 
Morpholino knockdown 
RNAi mediated gene knockdown technique is widely used in a variety of model systems 
from cell cultures to mammalian systems. Although there have been a few successful efforts 
to apply this technique in the zebrafish, RNAi mediated gene knockdown is not widely 
applicable in the zebrafish [24,35]. Instead, knockdown of gene function by morpholino 
antisense nucleotides is the most widely used reverse genetics technique to study genes of 
interest in the zebrafish [1]. Morpholinos are chemically synthesized nucleotides with 
morpholine rings, thereby resistant to breakdown by nucleases [34]. Usually morpholino 
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sequences are designed to bind in the vicinity of the start codon to block initiation of 
translation or to splice acceptor sequences to cause abberantly spliced mRNAs. 
Morpholinos are injected into freshly fertilized eggs and effectively block mRNA translation 
or splicing of target genes up to 5dpf, before becoming too diluted to efficiently interfere with 
translation. At this stage of development, most organs, including endocrines systems, are 
fully functional in zebrafish [29]. The biggest advantage of morpholinos is their ease of use 
and quick read-out. Together with the high fecundity of zebrafish, morpholinos can be 
injected into several hundreds of embryos in one experiment and resulting phenotypes are 
readily observed in those embryos a few days later (Figure 1). Furthermore, co-injection of a 
combination of up to three morpholinos can be performed to achieve double and triple 
knockdowns of genes of interest [31]. In addition, concentrations of morpholinos injected can 
be titrated in order to investigate dose-dependent resulting phenotypes. One exemplary 
application to the field of endocrinology is the downregulation of the zebrafish irx3a 
orthologue [39]. This transcriptional regulator is expressed in the kidney, hypothalamus and 
endoderm derived tissues. Morpholino-based downregulation of irx3a increased the mRNA 
expression level of ghrelin while decreased that of insulin, demonstrating an involvement of 
irx3a in the regulation of β- and ε-cells of the pancreas. 
Though highly efficient, knockdown experiments using morpholinos require optimization of 
the injection dose and careful observation of resulting phenotypes as there is a potential risk 
of off-target effects, which may cause unspecific phenotypes [10]. Also, the effectiveness of 
the downregulation needs to be carefully assessed, e.g. by demonstrating the reduction or 
absence of the target protein in western blots. Keeping these experimental precautions in 
mind, morpholino-based knockdown is one of the most advantageous techniques the 
zebrafish has to offer. In addition to the conventional knockdown of translation of target 
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mRNAs, morpholinos can also be used to block the maturation of microRNAs (miRNAs) as 
well as to inhibit their binding to the target mRNAs, facilitating assessment of target genes of 
miRNAs [44]. 
 
TILLING 
TILLING (targeted induced local lesions in genomes) is a combined method of forward and 
reverse genetics based on chemical mutagenesis to isolate mutants harboring point mutations 
in genes of interest [48]. Firstly, male fish are mutagenized by ENU (N-Nitroso-N-ethylurea), 
a chemical mutagen, and subsequently, mutations in target genes are sought by sequencing 
the target regions from genomes extracted from the mutagenized individuals (Figure 2A). 
Although TILLING is a technically efficient method to obtain fish with mutations in genes of 
interest, since it requires a large-scale sequencing of a large pool of individual fish, it is 
difficult to conduct as a routine technique in most individual laboratories. Therefore, 
community-based zebrafish mutation projects by TILLING were established by several 
consortia (eg. Sanger Institute) and the information and resources are shared via the zebrafish 
community database (http://zfin.org/). 
 
ZFNs 
Zinc finger nucleases (ZFNs) are artificial endonuclease enzymes originally introduced as a 
hybrid restriction enzyme [25]. ZFNs consist of two domains. One is the zinc finger motif 
domain that recognizes a specific sequence of genomic DNA and the other is the FokI 
restriction enzyme domain that cuts double-stranded DNA [11]. A DNA double-stranded 
break is repaired by homologous recombination or a non-homologous end joining (NHEJ). 
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As NHEJ is an error-prone process, it creates small deletion/insertion (´indel´) mutations in a 
site of lesion. Thus, by engineering the zinc finger domains to bind specific loci of genomes, 
it is possible to introduce mutations into genes of interest.  
ZFNs are injected into fertilized eggs at the one to two cell stages. Individuals harboring 
mutations in a target gene are subsequently identified and these founder fish are outcrossed to 
obtain an F1 generation. After confirming the mutations in the F1 generation, they are 
incrossed and the resulting F2 generation with a homozygous mutation in a gene of interest 
can be subject to analysis of the gene function. Although genes in the endocrine systems of 
zebrafish have not yet been targeted by ZFNs, there is a growing list of zebrafish lines 
generated by this technology [27]. 
Targeted mutagenesis by ZFNs is simple in theory and ZFNs are indeed a viable tool for 
targeted mutagenesis, but the production of validated ZFN pairs is technically challenging 
and costly. In addition, ZFNs have a potential risk to cause off-target effects, which may 
yield unspecific phenotype unrelated to the function of target genes [36]. One of the 
disadvantages of ZFNs is their complexity regarding the designing of DNA binding domains 
[50]. ZFN binding domain contains 3 to 4 DNA recognition modules, each of which 
recognizes 3 DNA bases. However, when all the modules are assembled as one DNA binding 
domain, the specificity of DNA binding can decrease and therefore, designing specific ZFN 
pairs that recognize specific loci of the genome is selective, making some genes unavailable 
for targeted knockout via ZFN.  
 
TALENs 
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Based on the same principal as ZFNs, the transcription activator-like effector nucleases 
(TALENs) are emerging as a new and efficient tool for targeted mutagenesis [5]. TALENs 
use the same functional domains, namely the restriction enzyme domain and the DNA 
binding domain. In the case of TALENs, the DNA binding domain is derived from plant 
pathogenic bacteria with TALE modules recognizing specific bases (Figure 2B) [4]. TALENs 
are far more flexible and much simpler to generate than ZFNs because each TALE module of 
the DNA recognition domain of TALENs consists of a cipher for one particular DNA base 
and can be easily assembled one by one. Although off-target effects of TALENs still need to 
be evaluated with more accumulating experience, TALENs are increasingly used as an easily 
accessible gene targeting technique for many laboratories. 
 
Transgenic Approaches 
Tissue specific expression of a transgene in in vivo system is a powerful tool for genetic 
studies. Transgenesis was historically the weakness of the zebrafish model system, but owing 
to extensive efforts to improve transgenesis in zebrafish, it turned into one of the most 
appealing features of zebrafish. There are several ways to enhance transgenesis in zebrafish, 
such as co-injection of I-SceI meganuclease, but the most common method currently largely 
in use is utilization of the Tol2 transposon system [14,22]. The Tol2 transposable elements 
were originally discovered in the Japanese medaka Oryzias latipes [23].  Co-injection of 
expression constructs containing transgenes flanked by the Tol2 elements with the 
transposase mRNAs greatly enhances the efficiency of transgenesis in zebrafish, including 
germ line transmission (Figure 3A). Together with the development of the gateway 
technology that significantly facilitates flexible assemblies of expression constructs, 
researchers can now fully exploit advantages of the zebrafish as a model system [26]. 
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GAL4/UAS 
The GAL4/UAS system is a standard approach in Drosophila [9]. Since the improvement of 
the transgenesis in zebrafish by the Tol2 system, use of the GAL4/UAS system has been 
becoming a more and more common approach in zebrafish [40,41]. By fusing a transgene of 
interest under the control of the UAS promoter, the GAL4/UAS system allows tissue specific 
expression of the transgene when combined with the tissue specific GAL4 driver line (Figure 
3B). Using this technology, overexpression of a gene of interest with tissue specificity can be 
achieved. The most advantageous feature of the GAL4/UAS system is that an array of GAL4 
driver lines can be combined with a range of UAS effector lines, allowing a multitude of 
spatiotemporal regulation of gene functions. The stable UAS transgenic zebrafish lines 
generated so far express fluorophores in GAL4 positive cells to visualize gene function and 
cell specific behaviors. Future work is expected to produce various UAS effector lines that 
activate or silence gene function under an array of multiple GAL4 driver lines [33]. 
 
Heat shock promoters 
Heat shock promoters drive expression of transgenes when the surrounding temperature is 
raised to 38°C, allowing temporal and spatial control of transgene expression (Figure 3C) 
[17]. This technique is a powerful tool when studying effects of overexpression of genes of 
interest at different time points during the development. In addition, being a small water-
living animal, the zebrafish is a particularly viable model system for this technique as the 
surrounding temperature is easily controlled [42]. One issue entailing the use of the heat 
shock promoters is a leakiness of the promoter activity, resulting in the basal expression of 
the downstream genes even at the permissive temperature [19]. However, this leakiness can 
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be circumvented by integrating this technique in the ligand-inducible Cre/loxP system [18]. 
Furthermore, a method using a modified soldering iron has been developed to enable a site-
specific heat induction in order to achieve spatial specificity of transgene control as well as 
temporal specificity [20,38]. 
 
Cre/loxP system 
One of the remaining challenges in zebrafish reverse genetics is to accomplish a conditional 
knockout/down technique (Figure 3D). In that respect, the mouse model is still the most 
sophisticated model system due to the well-established Cre/loxP system, by which mouse 
geneticists can manipulate genes of interest in a spatiotemporal manner at will [2]. It is a 
natural course of progress to apply the Cre/loxP system to the zebrafish model system to 
achieve the spatiotemporal control of gene expression, but shortage of a promoter/enhancer 
that ubiquitously drive expression of transgenes has been an obstacle [21,49]. Although 
several elements that are assumed to have broad control of genes have been identified, 
including h2afx, tbp and β-actin promoter, these expression driving elements are inactivated 
during the development and thus cannot be a proper ubiquitous promoter [3]. 
Recently, the promoter of the zebrafish ubiquitin, a ubiquitin peptide precursor, that is highly 
conserved from plants to humans, was isolated and shown to drive expression of transgenes 
at all stages of the zebrafish development and in all adult organs [32]. Subsequently, stable 
EGFP transgenic lines were generated using the ubiquitin promoter that showed strong 
ubiquitous expression of EGFP from an early stage of development to adulthood. 
Furthermore, the same group created ubi:creERt2 transgenic lines and detected Cre activity at 
various time points of development upon administration of tamoxifen. By crossing this 
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ubi:creERt2 lines with ubi reporter transgenics flanked by two loxP sites, a strong Cre 
mediated reporter activity was successfully demonstrated.  
Although the ubi promoter activity reported in this study varies depending on cell types in 
different tissues and loxP reporter activity upon Cre exposure has positional effects, isolation 
of a ubiquitous promoter and application of the Cre/loxP system in zebrafish has 
demonstrated the potential of this animal model to become a more sophisticated and flexible 
system in the near future. 
 
Targeted cell ablation 
Cell type specific ablation is an important tool for regeneration studies and enhanced 
transgenesis made targeted cell ablation one of the powerful methods in zebrafish. Bacterial 
nitroreductase (NTR) converts metronidazole (Met) into a cytotoxic agent [6]. By expressing 
NTR under a promoter that drives expression in a cell type specific manner, cell populations 
of interest can be ablated in a time point specific manner upon administration of Met. One 
example of the application of this technique is that insulin producing β-cells were 
successfully ablated in the pancreas, resulting in reduced mass of β-cells [37]. This technique 
can be combined with the GAL4/UAS system, where NTR is expressed under the UAS 
promoter, which is transactivated by the GAL4 driver in a particular cell type [15]. With this 
combination, targeted cell ablation can be performed with more flexibility.  
 
Conclusion 
The zebrafish offers a diverse range of approaches to study human diseases. Recent 
advancements in reverse genetics technologies further accelerate the use of the zebrafish as a 
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model system. Many of the key factors in endocrine systems are conserved from humans to 
zebrafish and therefore, considering the useful biological features, together with reverse 
genetics techniques in hand, the zebrafish should attract more attention as a major organism 
to study endocrinology. Endocrinology research using zebrafish has the potential to provide 
more insights into our understanding of human endocrine systems and contribute to 
elucidations of genetic mechanisms of human diseases caused by disruptions of the endocrine 
systems. 
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Figure 1. Overview of a knockdown experiment by morpholino antisense nucleotides. A 
chemical structure of a morpholino is shown. Morpholinos are normally injected into 
fertilized embryos at the one cell stage. Effects of knockdowns of target genes are readily 
observed in these embryos up to 5dpf. 
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Figure 2. Schematic representation of procedures to obtain knockout zebrafish by TILLING 
and TALENs. (A) In a conventional TILLING approach, as a first step, male fish are 
mutagenized by ENU and outcrossed to obtain the F1 founder generation. The resulting F1 
fish are screened (e.g. by PCR based techniques and sequencing) for individuals with 
mutations in genes of interest. The mutation carriers are then crossed with wild type female 
fish to obtain the F2 generation. Incrossing of the F2 families results in generation of the F3 
fish with homozygous mutations in target genes. “m” indicates a mutation in genes of interest. 
(B) In a TALEN approach, gene specific TALENs are injected into fertilized embryos at the 
one to two cell stage. These embryos are raised to adulthood and individual fish carrying 
mutations (founder fish) are screened. The founder fish are then crossed with wild type fish to 
obtain the F1 generation. Incrossing of the F1 families results in the F2 families that include 
fish that are homozygous for mutations in target genes. Of note, it is one generation shorter to 
obtain homozygote fish in the TALEN approach than the TILLING approach. A schematic of 
a TALEN is also shown. Four colored ovals represent each TALE module of the DNA 
binding domain of TALENs that recognizes a specific base. 
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Figure 3. Schemes for transgenic approaches. (A) Tol2 mediated transgenesis. Tol2 
expression constructs contain transgenes flanked by the Tol2 transposable elements. Co-
injection of the Tol2 constructs with mRNAs for transposase greatly enhances efficiency of 
integration of transgenes. (B) GAL4/UAS system. Upon crossing of a GAL4 driver line and 
UAS effector line, expression of GAL4 driven by a tissue specific promoter transactivates 
expression of a transgene through the UAS effector element in the resulting embryos. (C) 
Heat induced expression of a transgene. The heat shock promoter drives expression of a 
downstream transgene upon rise of the temperature. (D) Conditional knockout via the 
inducible Cre/loxP system. The Cre activity induced upon administration of tamoxifen 
excises a gene of interest flanked by loxP sites expressed under the ubiquitous promoter. By 
using a tissue specific promoter upstream of creERt2, conditional tissue specific knockouts can 
be achieved. Blue triangles indicate the loxP element. 
